Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy. [electronic resource]
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Dec 2000
- 1516-8 p. digital
Publication Type: Journal Article
1058-4838
10.1086/317482 doi
Adult Antiviral Agents--therapeutic use Female Hematopoietic Stem Cell Transplantation--adverse effects Humans Male Middle Aged Parainfluenza Virus 3, Human Prospective Studies Respiratory Tract Infections--drug therapy Respirovirus Infections--drug therapy Ribavirin--therapeutic use Treatment Outcome